Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,706 shares at $650.00 ($1.1M) on 2020-07-07, disclosed to the SEC on 2020-07-08.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-01-04 | $1.0M | — | Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |